ArticleScientific reports2026
Phytogenic molybdenum nanoparticles using Pterocarpus santalinus: characterisation, antioxidant, antimicrobial, seed priming and nitrogen fixation activities.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study reports the phytogenic synthesis and multifunctional evaluation of molybdenum oxide nanoparticles (MoONPs) using Pterocarpus santalinus leaf extract as a natural reducing and stabilising agent. The synthesised MoONPs exhibited a distinct surface plasmon resonance peak at 364 nm, confirming their formation. FE-SEM/EDAX revealed spherical, high-purity nanoparticles, while XRD confirmed an orthorhombic crystalline phase with an average crystallite size of 35.71 nm. FT-IR identified functional groups involved in capping and stabilisation. MoONPs demonstrated significant antioxidant activity (40.21% ABTS inhibition at 100 µg/mL), comparable to ascorbic acid and superior to the extract alone. They also exhibited strong antimicrobial activity against phytopathogenic bacteria (X. campestris, P. syringae, C. michiganensis, S. aureus) and fungi (A. niger, A. flavus), demonstrating notable antimicrobial activity compared to standard controls. As a seed-priming agent for Arachis hypogaea, MoONPs enhanced germination (up to 227.5%), vigour index (up to 379.4), and root/shoot elongation. MoONPs boosted nitrate reductase activity by 67%, increased chlorophyll content by 79%, and improved biomass accumulation and plant height. Collectively, these findings indicate that Pterocarpus santalinus-mediated MoONPs exhibit multifunctional properties with potential applications as nano-fertilizers and biocontrol agents in agriculture; however, further studies are required to evaluate their safety and environmental impact before practical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.